Physician

Alejandra Fuentes Ergle, M.D.

According to 2025 Medicare claims, Alejandra Ergle, M.D. (NPI: 1194162263) practices medical oncology in the Fort Lauderdale-Pompano Beach-Sunrise, FL market, with the plurality of this provider's patient population coming from Broward, FL. This provider's primary affiliated billing organization is SOUTH BROWARD HOSPITAL DISTRICT (NPI: 1780691865; TIN: 596014973) and primary practice location at 33026-4119. Ergle is affiliated with the Broward Guardian, LLC (ACO ID: A2286), participating under the MSSP model.

Ergle's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 108 traditional Medicare patients, billed 284 HCPCS/CPT codes, and received $26,308 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 452 prescription claims across 125 beneficiaries totaling $706,402 in drug costs, led by Verzenio (Abemaciclib). 2022 DME data shows 11 claims. Open Payments data shows 3 records totaling $180. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $2,030 and ending at $26,308. Concurrently, Part D prescription costs have risen steadily, from $2,874 to $706,402. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	16	24	$2,030
2020	45	184	$20,980
2021	66	257	$29,097
2022	84	200	$19,113
2023	79	208	$18,996
2024	108	284	$26,308

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	11	23	$2,874
2016	21	31	$923
2017	49	125	$6,135
2018	39	160	$107,616
2019	31	144	$316,161
2020	49	225	$86,135
2021	69	340	$207,278
2022	87	298	$214,014
2023	90	301	$383,994
2024	125	452	$706,402

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	12	$272
2019	N/R	N/R	N/R
2020	N/R	11	$68
2021	N/R	N/R	N/R
2022	N/R	11	$569
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	12	12	$147
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	33	144	$109
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	61	95	$68
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	18	21	$45

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Verzenio	Abemaciclib	22	616	$322,624
Anastrozole	Anastrozole	167	10,769	$2,075
Exemestane	Exemestane	19	870	$1,736
Raloxifene Hcl	Raloxifene Hcl	11	810	$466
Tamoxifen Citrate	Tamoxifen Citrate	23	1,724	$451

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$180	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alejandra Fuentes Ergle, M.D.?

Tedicare shows public-source Medicare data for Alejandra Fuentes Ergle, M.D. (NPI 1194162263), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alejandra Fuentes Ergle, M.D. have ACO affiliation data?

Alejandra Fuentes Ergle, M.D. is shown with ACO affiliation data for Broward Guardian, LLC (MSSP, ACO ID A2286).

What billing organization is linked to Alejandra Fuentes Ergle, M.D.?

Alejandra Fuentes Ergle, M.D. is linked to SOUTH BROWARD HOSPITAL DISTRICT (billing NPI 1780691865) in the available physician profile data.

Does Alejandra Fuentes Ergle, M.D. have Open Payments data?

Alejandra Fuentes Ergle, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.